Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Mirum Pharmaceuticals, Inc. | Director | Restricted Stock Units | 5.7K | $120K | $21.05 | Jun 5, 2024 | Direct |
Aileron Therapeutics, Inc. | Director | Stock Option (right to buy) | 35K | Dec 2, 2024 | Direct | ||
KalVista Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 10K | Oct 3, 2024 | Direct | ||
Mirum Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 8.78K | Jun 5, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ALRN | Aileron Therapeutics, Inc. | Dec 2, 2024 | 1 | $0 | 4 | Dec 6, 2024 | Director |
KALV | KalVista Pharmaceuticals, Inc. | Oct 3, 2024 | 1 | $0 | 4 | Oct 4, 2024 | Director |
ALRN | Aileron Therapeutics, Inc. | Aug 20, 2024 | 1 | $0 | 4 | Aug 22, 2024 | Director |
MIRM | Mirum Pharmaceuticals, Inc. | Jun 5, 2024 | 2 | $0 | 4 | Jun 7, 2024 | Director |
KALV | KalVista Pharmaceuticals, Inc. | Apr 18, 2024 | 1 | $0 | 4 | Apr 22, 2024 | Director |
KALV | KalVista Pharmaceuticals, Inc. | Apr 18, 2024 | 0 | $0 | 3 | Apr 22, 2024 | Director |
ALRN | AILERON THERAPEUTICS INC | Oct 31, 2023 | 1 | $0 | 4 | Nov 2, 2023 | Director |
ALRN | AILERON THERAPEUTICS INC | Oct 31, 2023 | 0 | $0 | 3 | Nov 2, 2023 | Director |
MIRM | Mirum Pharmaceuticals, Inc. | Jun 12, 2023 | 1 | $0 | 4 | Jun 14, 2023 | Director |
MIRM | Mirum Pharmaceuticals, Inc. | Jun 2, 2022 | 1 | $0 | 4 | Jun 6, 2022 | Director |
MIRM | Mirum Pharmaceuticals, Inc. | Aug 19, 2021 | 1 | $0 | 4 | Aug 20, 2021 | Director |
MIRM | Mirum Pharmaceuticals, Inc. | Aug 19, 2021 | 0 | $0 | 3 | Aug 20, 2021 | Director |